Virtual Social Interaction and Psychological Capital in Chemotherapy Patients: A Randomized Controlled Trial.

Cancer MedOct 30, 2026

Masome Rafat, Ali Pourhabib, Amaneh Mahmoudian et al.

✦ AI-curated · Sources linked

In 30 seconds

This single-blind randomized controlled trial evaluated a six-week virtual social interaction program for 76 patients receiving chemotherapy at one Iranian hospital. Participants were assigned to the intervention or standard care, and psychological capital (PsyCap) was assessed before and after the program. The intervention group’s total PsyCap score increased by 23.6 points; self-efficacy, resilience, hope, and optimism also improved significantly (p < 0.0001). Adjusted analyses accounting for baseline scores and age supported a substantial intervention effect. The authors note that larger, multicentre studies are needed before the findings can be confidently generalized.

Key findings

  • Total PsyCap increased by 23.6 points in the virtual-interaction intervention group.
  • Self-efficacy and resilience each increased by 5.8 points; hope increased by 5.5 and optimism by 6.5 (p < 0.0001).
  • Adjusted ANCOVA models accounting for baseline scores and age showed Δ SMD > 1.

Why it matters

Psychological distress during cancer treatment remains an important concern, and this trial suggests that structured virtual group interaction may improve psychological resources in patients receiving chemotherapy. The findings provide evidence for further evaluation of remote psychosocial support, while the single-hospital setting and need for replication limit conclusions about broader implementation.

What to keep in mind

The trial was conducted at a single hospital, used convenience sampling and alternating odd-even allocation, and the authors call for larger, multicentre replication before generalizing the findings.

Source

Published in Cancer Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.